CCM
BMY icon

Chiron Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Chiron Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,100
Closed -$6K – 125
2020
Q3 		$6K Buy
+2,100
New +$126K ﹤0.01% 342

Other funds holding BMY

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Chiron Capital Management's BMY Position: Q2 2026 in Review

Chiron Capital Management increased its Bristol-Myers Squibb (BMY) stake by 8.2% in Q2 2026, buying an estimated $900K and bringing the position to 206,970 shares worth $11.9M. The position accounts for 10.7% of the portfolio, ranked #1.

Chiron Capital Management first reported a position in BMY in Q3 2020 and has held it in 23 quarters since. The position peaked at $48.3M in Q1 2021. 672 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Chiron Capital Management held 206,970 shares of Bristol-Myers Squibb worth $11.9M as of Q2 2026.
  • Chiron Capital Management bought 15,682 Bristol-Myers Squibb shares in Q2 2026, an estimated $900K.
  • Bristol-Myers Squibb made up 10.7% of Chiron Capital Management's portfolio in Q2 2026, its #1 holding.
  • Chiron Capital Management first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 23 quarters since.
  • Chiron Capital Management's Bristol-Myers Squibb position peaked at $48.3M in Q1 2021.
  • 672 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Chiron Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.